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Abstract. 
 
The replication licensing factor (RLF) is an 
essential initiation factor that is involved in preventing 
re-replication of chromosomal DNA in a single cell cy-
cle. In 
 
Xenopus
 
 egg extracts, it can be separated into 
two components: RLF-M, a complex of MCM/P1 
polypeptides, and RLF-B, which is currently unpuri-
fied. In this paper we investigate variations in RLF ac-
tivity throughout the cell cycle. Total RLF activity is 
low in metaphase, due to a lack of RLF-B activity and 
the presence of an RLF inhibitor. RLF-B is rapidly acti-
vated on exit from metaphase, and then declines during 
interphase. The RLF inhibitor present in metaphase ex-
tracts is dependent on the activity of cyclin-dependent 
kinases (Cdks). Affinity depletion of Cdks from 
metaphase extracts removed the RLF inhibitor, while 
Cdc2/cyclin B directly inhibited RLF activity. In 
metaphase extracts treated with the protein kinase in-
hibitor 6-dimethylaminopurine (6-DMAP), both cyclin 
B and the RLF inhibitor were stabilized although the 
extracts morphologically entered interphase. These re-
sults are consistent with studies in other organisms that 
invoke a key role for Cdks in preventing re-replication 
of DNA in a single cell cycle.
 
D
 
uring
 
 each S phase of the eukaryotic cell division
cycle, the entire genome is precisely duplicated.
To achieve this, many hundreds or thousands of
replication origins must each fire once and only once in
each S phase. Studies using cell-free systems derived from
 
Xenopus
 
 eggs have revealed that re-replication of chromo-
somal DNA in a single cell cycle is prevented by the action
of two distinct replication signals (Blow and Laskey, 1988;
Chong et al., 1996). The first signal, replication licensing
factor (RLF)
 
1
 
, “licenses” chromosomal DNA by putting
replication origins into an initiation-competent state. The
second signal, S-phase promoting factor (SPF), induces li-
censed origins to initiate and, in doing so, removes the li-
cence. To achieve precise duplication of chromosomal
DNA, the licensing and initiation signals must act on the
DNA sequentially, and never at the same time. This is
achieved in two different ways. First, active RLF cannot
cross the nuclear envelope, so it can only license DNA
when the nuclear envelope has broken down in mitosis
(Blow and Laskey, 1988; Leno et al., 1992; Coverley et al.,
1993; Blow, 1993); in contrast, SPF can only initiate DNA
replication on licensed DNA within an intact nucleus
(Blow and Watson, 1987; Newport, 1987; Sheehan et al.,
1988; Blow and Sleeman, 1990). Secondly, both activities
are periodic in the cell cycle: RLF is abruptly activated af-
ter the metaphase–anaphase transition and decays during
interphase (Blow, 1993), while SPF activity can only be de-
tected during interphase (Blow and Nurse, 1990). The spa-
tial separation of RLF and SPF activities is thereby en-
hanced by a temporal regulation.
The activation of RLF that occurs at the metaphase–
anaphase transition in 
 
Xenopus
 
 can be blocked by certain
protein kinase inhibitors, such as 6-dimethylaminopurine
(6-DMAP), that are known to inhibit cyclin-dependent ki-
nases (Blow, 1993; Kubota and Takisawa, 1993; Vesely et al.,
1994). The licensing system has been subjected to bio-
chemical and immunological analysis using extracts treated
with these kinase inhibitors (Chong et al., 1995; Kubota et
al., 1995). RLF activity can be separated chromatographi-
cally into two essential components, RLF-M and RLF-B,
both of which are required for licensing (Chong et al.,
1995). RLF-M has been purified to apparent homogeneity,
and it consists of a complex of all six currently identified
members of the 
 
Xenopus
 
 MCM/P1 family, XMcm2–
XMcm7 (Chong et al., 1995, 1996; Thömmes, P., Y.
Kubota, H. Takisawa, and J.J. Blow, manuscript submitted
for publication). Anti-XMcm3 antibodies coprecipitated
all six 
 
Xenopus
 
 MCM/P1 proteins in a complex closely re-
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sembling the RLF-M complex (Kubota et al., 1995; Ma-
dine et al., 1995
 
a
 
,
 
b
 
; Thömmes, P., Y. Kubota, H. Takisawa,
and J.J. Blow, manuscript submitted for publication) and
depleted the extracts of RLF-M activity (Chong et al.,
1995).
 
MCM
 
/
 
P1
 
 genes were originally identified in 
 
Saccharo-
myces cerevisiae
 
 in a screen for mutants unable to effi-
ciently initiate replication at particular replication origins
(Maine et al., 1984), due to a failure of the initiation pro-
cess (Maiti and Sinha, 1992; Yan et al., 1993). The proteins
show cell cycle–dependent changes in subnuclear localiza-
tion, being observed within the nucleus only during late
mitosis and G1 (Hennessy et al., 1990; Yan et al., 1993;
Dalton and Whitbread, 1995). Homologous 
 
MCM
 
/
 
P1
 
 genes
have been identified in a wide range of eukaryotes includ-
ing insects, plants, amphibians, and mammals, where they
fall into six related groups designated 
 
MCM2–MCM7
 
(Chong et al., 1996; Kearsey et al., 1996). Consistent with
their role in yeast, MCM/P1 proteins in higher eukaryotes
are required for DNA replication (Kimura et al., 1994;
Todorov et al., 1994; Chong et al., 1995; Kubota et al.,
1995; Madine et al., 1995
 
a
 
;
 
 
 
Treisman et al., 1995) and be-
have in accordance with their role as a central component
of the licensing system. They associate tightly with chro-
matin during late mitosis and G1, but are removed during
replication (Kimura et al., 1994; Chong et al., 1995; Ku-
bota et al., 1995; Madine et al., 1995
 
a
 
,
 
b
 
; Todorov et al.,
1995; Coué et al., 1996). Reassociation of XMcm3 with
chromatin, which is required before an additional round of
replication can take place, only occurs after permeabiliza-
tion or breakdown of the nuclear envelope (Chong et al.,
1995; Kubota et al., 1995; Madine et al., 1995
 
a
 
,
 
b
 
). The li-
censing of chromatin by RLF-M and RLF-B in 
 
Xenopus
 
requires the presence of the 
 
Xenopus
 
 origin recognition
complex (ORC) on the chromatin (Rowles et al., 1996).
In this paper we analyze the cell cycle control of RLF
activity in 
 
Xenopus
 
 egg extracts. Total RLF activity is
sharply periodic in the cell cycle. An RLF inhibitor is
present in metaphase extracts and appears to be directly
dependent on the activity of cyclin-dependent kinases.
When the inhibitor is removed or diluted away, RLF-M,
but not RLF-B, activity can be detected. RLF-B, but not
RLF-M, activity is unstable in interphase and decays over
a period of 60–120 min. However, the decay of RLF-B ac-
tivity in interphase is not associated with activation of an
RLF inhibitor and does not depend on cyclin-dependent
kinases.
 
Materials and Methods
 
Preparation and Use of Xenopus Egg Extract
 
Metaphase-arrested and interphase 
 
Xenopus
 
 extract was prepared as
described (Blow, 1993) and stored in 20-
 
m
 
l aliquots in liquid nitrogen.
Just before use, extract was thawed at room temperature and supple-
mented with 250 
 
m
 
g/ml cycloheximide, 25 mM phosphocreatine, and 15
 
m
 
g/ml creatine phosphokinase. Metaphase-arrested extract was released
into interphase by the addition of 0.3 mM CaCl
 
2
 
. To block RLF activation,
metaphase-arrested extracts were supplemented with 3 mM 6-DMAP and
mixed thoroughly before CaCl
 
2
 
 addition (6-DMAP–treated extract). For
replication assays, extract was supplemented with 1/200 vol 10 mCi/ml
[
 
a
 
32
 
P]dATP (Amersham Intl., Little Chalfont, UK). Extract incubations
were performed at 23
 
8
 
C.
Suc1 depletion was performed essentially as described (Blow and
Nurse, 1990). Metaphase extract was mixed with an equal volume of
p13
 
suc1
 
-coupled Sepharose (10 
 
m
 
g Suc1/ml beads, washed in LFB1 [40 mM
Hepes KOH, pH 8.0, 20 mM K
 
2
 
HPO
 
4
 
/KH
 
2
 
PO
 
4
 
, pH 8.0, 2 mM MgCl
 
2
 
; 1
mM EGTA, 2 mM DTT, 10% sucrose, 1 
 
m
 
g/ml each of leupeptin, pepsta-
tin, and aprotinin] and incubated on a rotating wheel at 4
 
8
 
C for 60 min.
The supernatant was recovered by spinning the bead/extract slurry past a
glass ball wedged in a sawn-off yellow Gilson tip in an Eppendorf tube.
 
Preparation of DNA Templates
 
Demembranated 
 
Xenopus
 
 sperm nuclei were prepared by lysolecithin
treatment as described (Blow and Laskey, 1986). They were assembled
into chromatin in 6–DMAP-treated extract, to form “6-DMAP chroma-
tin” as follows (Chong et al., 1995, 1997): 80 
 
m
 
l of a metaphase-arrested
extract was supplemented with phosphocreatine, creatine phosphokinase,
3 mM 6-DMAP, and CaCl
 
2
 
 as described above, and then supplemented
with 1.3 
 
3
 
 10
 
6
 
 demembranated sperm nuclei (
 
z
 
50 ng DNA per 
 
m
 
l ex-
tract). The mixture was incubated for 12 min at 23
 
8
 
C, and then diluted in 1
ml NIB (50 mM KCl; 50 mM Hepes KOH, pH 7.6; 5 mM MgCl
 
2
 
; 2 mM
DTT, 0.5 mM spermidine 3HCl; 0.15 mM spermine 4HCl; 1 
 
m
 
g/ml each leu-
peptin, aprotinin, and pepstatin) and underlayered with 100 
 
m
 
l NIB sup-
plemented with 15% sucrose. The chromatin was isolated by centrifuga-
tion in a swing-out rotor at 6,200 
 
g
 
 for 5 min at 4
 
8
 
C. The pellet was
resuspended in 45 
 
m
 
l NIB (to a final concentration of 80 ng DNA/per 
 
m
 
l)
and frozen in 5-
 
m
 
l aliquots in liquid nitrogen.
 
Preparation of RLF-B and RLF-M
 
Polyethylene glycol (PEG)–fractionated RLF-B and RLF-M were pre-
pared as described (Chong et al., 1995, 1997). Eggs were dejellied in 2%
cysteine solution, washed three times in Barth solution (88 mM NaCl, 2 mM
KCl, 1 mM MgCl
 
2
 
, 15 mM Tris HCl, pH 7.4, 0.5 mM CaCl
 
2
 
), and then in-
cubated for 5–10 min in 100 ml Barth plus 20 
 
m
 
l 10 
 
m
 
g/ml calcium iono-
phore A23187. The activated eggs were then washed three times in Barth
solution at 23
 
8
 
C and three times in EB (50 mM KCl, 50 mM Hepes KOH,
pH 7.6, 5 mM MgCl
 
2
 
, 2 mM DTT) at 4
 
8
 
C. All additional steps were per-
formed at 4
 
8
 
C or on ice. Eggs were packed by centrifuging at 800 g in a
swing-out rotor for 1 min. Excess buffer and sick eggs, which float to the
surface during this treatment, were then removed. Packed eggs were spin-
crushed by centrifugation at 10,000 
 
g
 
 for 10 min in a swing-out rotor. The
cytoplasmic layer was taken, supplemented to a final concentration of 10
 
m
 
g/ml cytochalasin B and 15% EDB-S (50 mM KCl, 50 mM Hepes KOH,
pH 7.6, 10% sucrose, 2 mM DTT, 0.4 mM MgCl
 
2
 
, 0.4 mM EGTA, 1 
 
m
 
g/ml
each of pepstatin, leupeptin, and aprotinin), and then diluted with 4 vol of
LFB1 containing 50 mM KCl and 0.5 mM freshly added PMSF. This di-
luted extract was spun at 60,000 
 
g
 
 for 20 min at 4
 
8
 
C in a swing-out rotor.
The supernatant (“licensing factor extract”) was decanted, drop frozen in
liquid nitrogen, and stored at 
 
2
 
70
 
8
 
C. Since it is fivefold diluted over neat
extract, licensing factor extract is designated a concentration of 0.2
 
3
 
.
Differential PEG precipitation was performed as follows (Chong et al.,
1995, 1997): licensing factor extract was supplemented with 0.075 vol of a
50% PEG solution (50% PEG 6000 [BDH Chemicals Ltd., Poole, UK] in
LFB1) to give a final concentration of 3.5% PEG. Extract was incubated
on ice for 30 min, and then centrifuged at 10,000 
 
g
 
 for 10 min in a fixed-
angle rotor. The supernatant was decanted, and residual PEG solution
was removed after an additional brief spin. The pellet was then resus-
pended in LFB1 at 1/25 of the original volume of licensing factor extract
to give 5
 
3
 
 concentrated RLF-B, and was stored in aliquots at 
 
2
 
70
 
8
 
C. The
supernatant was supplemented with an additional 0.11 vol of a 50% PEG
solution, giving a final concentration of 9% PEG, incubated on ice, and
pelleted as before. The pellet was resuspended in LFB1 at 1/25 of the orig-
inal volume, to give 5
 
3
 
 concentrated RLF-M, and was stored in aliquots
at 
 
2
 
70
 
8
 
C.
RLF-M was further fractionated on Q Sepharose to produce RLF-
M
 
inter
 
 as described (Chong et al., 1995, 1997). RLF-M produced by PEG
precipitation was diluted to 1
 
3
 
 in LFB1 plus 100 mM KCl and was ad-
sorbed in batch for 30 min at 4
 
8
 
C onto an equal volume of loose Q
Sepharose (Pharmacia, Uppsala, Sweden) preequilibrated in LFB1 plus
100 mM KCl. The media was then packed into a column, washed with
LFB1 plus 100 mM KCl, and eluted as a step in LFB1 plus 325 mM KCl.
Eluted material was reprecipitated with PEG and resuspended in LFB1.
RLF-M
 
meta
 
 was produced in the same way as RLF-M
 
inter
 
, except that the
starting material was metaphase-arrested extract.
For the maturation promoting factor (MPF) inhibition experiment (see
Fig. 4 
 
b
 
), RLF-M from the Q Sepharose step was further purified by phe- 
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nyl Sepharose chromatography and gel filtration, as previously described
(Chong et al., 1995, 1997). For this experiment, the RLF-B preparation
was also further purified, according to the protocol previously described
for 
 
Xenopus
 
 ORC (Rowles et al., 1996; Chong et al., 1997). Briefly, PEG-
fractionated RLF-B was bound to phosphocellulose equilibrated in LFB1
plus 150 mM KCl, and then step-eluted in LFB1 plus 500 mM KCl. Eluted
material, containing both RLF-B and 
 
Xenopus
 
 ORC activity, was precipi-
tated with 40% ammonium sulfate, and the pellet was resuspended in
LFB1 for assay.
 
Licensing Assay
 
RLF was assayed in a two-step protocol as described (Chong et al., 1995,
1997). 2-
 
m
 
l samples to be assayed were incubated with 0.3 
 
m
 
l 6-DMAP
chromatin (80 ng DNA/
 
m
 
l) for 15 min for the “licensing reaction.” In as-
says for individual components, the 2-
 
m
 
l samples were typically composed
of 1-
 
m
 
l fraction of interest, plus 1-
 
m
 
l PEG-cut RLF-B and/or RLF-M di-
luted to 0.5
 
3
 
 in LFB1, plus 50 mM KCl and 2.5 mM Mg-ATP. For extract
dilution experiments, dilutions were performed with LFB1 plus 50 mM KCl.
Once the licensing reaction was finished, 5.7 
 
m
 
l 6-DMAP–treated extract
containing cycloheximide, phosphocreatine, creatine phosphokinase,
6-DMAP, CaCl
 
2
 
 and [
 
a
 
32
 
P]dATP were added. The incubation was contin-
ued for an additional 90 min at 23
 
8
 
C (the “replication reaction”). Replica-
tion reactions were terminated by the addition of 150 
 
m
 
l Stop-C (20 mM
Tris HCl, pH 7.5, 5 mM EDTA, 0.5% SDS) plus 0.2 
 
m
 
g/ml proteinase K
and incubated at 37
 
8
 
C for 15 min. TCA precipitation was performed as de-
scribed (Blow and Laskey, 1986; Chong et al., 1997), and the total DNA
synthesized (in ng DNA/
 
m
 
l) was calculated, assuming 50 
 
m
 
M endogenous
dATP in the extract (Blow and Laskey, 1986). Bromodeoxyuridine triphos-
phate (BrdUTP) density substitution was performed as described (Blow
and Laskey, 1986).
 
Alkaline Agarose Gel Electrophoresis
 
Reactions for agarose gel electrophoresis were stopped by digesting with
Stop-N (20 mM Tris-Cl, 200 mM NaCl, 5 mM EDTA, 0.5% SDS, pH 8.0)
containing 2 
 
m
 
g/ml RNase A and 200 
 
m
 
g/ml Proteinase K for 30 min at
37
 
8
 
C. DNA was extracted sequentially with phenol, phenol-chloroform,
and chloroform, and then precipitated with ethanol. Pellets were resus-
pended in alkali gel loading buffer (50 mM NaOH, 1 mM EDTA, 1.25%
Ficoll, 0.0125% bromocresol green). Alkaline gels were prepared by add-
ing the required amount of agarose to 50 mM NaCl and 1 mM EDTA.
Once set, the gels were allowed to equilibrate for 1 h in alkaline gel run-
ning buffer (30 mM NaOH, 1 mM EDTA), and then were run at 2 V/cm.
After electrophoresis was complete, gels were fixed in 7% TCA, dried,
and autoradiographed.
 
Cip1 and Cdc2/Cyclin B
 
Glutathione-
 
S
 
-transferase (GST)–tagged Cip1 was prepared as described
(Strausfeld et al., 1994). It was added to 
 
Xenopus
 
 extracts at 150 nM, an
amount sufficient to inhibit DNA replication by 
 
.
 
95% (Strausfeld et al.,
1994). Purified Cdc2/cyclin B was purchased from Upstate Biotechnology
Inc.(Lake Placid, NY) and was used in the licensing reaction at a final con-
centration of 1.25 ng/
 
m
 
l.
 
Antibodies and Western Blotting
 
For Western blotting, chromatin was isolated from extract as described for
the preparation of 6-DMAP chromatin, except that the NIB buffer was
supplemented with 0.1% NP-40 (Chong et al., 1995, 1997). Chromatin pel-
lets were resuspended in gel loading buffer, electrophoresed, and Western
blotted by standard techniques. Anti-XMcm3 rabbit polyclonal antibodies
were raised against recombinant GST-tagged XMcm3 (amino acids 423–
798) produced from the construct described by Madine et al. (1995
 
a
 
).
 
35
 
S Labeling and Autoradiography
 
200 
 
m
 
Ci [
 
35
 
S]methionine (Amersham Intl.) was dried under vacuum and
redissolved in 40 
 
m
 
l metaphase-arrested extract supplemented with phos-
phocreatine and creatine phosphokinase. The extract was incubated for 30
min at 23
 
8
 
C to label newly synthesized proteins, before the addition of 250
 
m
 
g/ml cycloheximide. Extract was then supplemented with various con-
centrations of 6-DMAP and then with 0.3 mM CaCl
 
2
 
, before being incu-
bated for an additional 30 min at 23
 
8
 
C to allow cyclin degradation to oc-
cur. Cyclin–cyclin-dependent kinase (Cdk) complexes were then collected
on p13suc1 beads at 48C for 45 min. The beads were washed several times,
and then were resuspended in sample loading buffer for electrophoresis
and autoradiography according to standard techniques.
Results
Quantification of RLF-M Required
for DNA Replication
RLF-M consists of a complex of MCM/P1 proteins, includ-
ing XMcm3 (Chong et al., 1995). To correlate the amount
of RLF-M activity in Xenopus extracts with the amount of
XMcm3 protein, we performed quantitative Western blot-
ting on extracts and on chromatin assembled in these ex-
tracts (Fig. 1 a). An estimate of 75–150 mg XMcm3 protein
per ml Xenopus extract (0.75–1.5 mM) was provided by a
number of duplicate blots (e.g., Fig. 1 a, lanes 1 and 2 and
17–19). Fig. 1 a also quantifies the association of XMcm3
with chromatin. Demembranated Xenopus sperm nuclei
(Fig. 1, lanes 10–16) or chromatin previously assembled in
6-DMAP–treated extract (6-DMAP chromatin; Fig. 1,
lanes  3–9) were briefly incubated with serial dilutions of
Xenopus egg extract. Chromatin was then isolated by cen-
trifugation through sucrose and immunoblotted for
XMcm3. As more extract was incubated with a fixed quan-
tity of chromatin, the amount of chromatin-associated
XMcm3 increased. Only at the highest concentrations of
DNA (6–12 ng DNA per ml extract) was there any sign of
the chromatin becoming saturated with XMcm3. Compari-
son with the recombinant XMcm3 standard (Fig. 1, lanes 1
and 2) suggests that the extract can assemble in excess of
30 ng XMcm3 onto 300 ng DNA, equivalent to one
XMcm3 molecule bound to every 1.5 kb of DNA on aver-
age. Previous studies have estimated that the replicon size
of the early Xenopus embryo is 10–20 kb (Blow and Wat-
son, 1987; Mahbubani et al., 1992; Hyrien and Méchali,
1993), suggesting that there may be .10 XMcm3 mole-
cules bound to each replicon.
Fig. 1 b examines the RLF activity of chromatin licensed
with different dilutions of interphase extract. Chromatin
was licensed with serial dilutions of extract, and then
transferred to 6-DMAP–treated extract (lacking RLF ac-
tivity) supplemented with [a32P]dATP. At different times
after transfer, the amount of DNA synthesis was mea-
sured. When incubated in extract at concentrations of
above 1/4–1/8 (corresponding to 100–200 ng DNA per ml
neat extract), chromatin was efficiently licensed, leading
to almost complete replication after an additional 90-min
incubation in 6-DMAP–treated extract. This is similar to
replication rates seen in untreated extract. When licensed
with lower amounts of extract (1/16 dilution and below),
the chromatin replicated at a lower rate, as though only a
fraction of the replication origins had initiated. Compari-
son of Fig. 1 a and 1 b suggests that maximal replication
rates were still seen with subsaturating quantities of
XMcm3 assembled onto the chromatin.
Cell Cycle Variation in RLF Activity
The Xenopus egg is arrested at metaphase of meiosis II.
At fertilization, a calcium wave is released that overcomes
the metaphase arrest, and the early embryo embarks on a
series of 12 rapid cell cycles. Extracts prepared from unfer-The Journal of Cell Biology, Volume 136, 1997 128
tilized eggs maintain the metaphase arrest and can be re-
leased into interphase by addition of CaCl2 (Lohka and
Masui, 1984). RLF activity is low in such metaphase-
arrested extracts, but it rapidly increases upon CaCl2 addi-
tion (Blow, 1993). We first determined the quantity of
RLF-B and RLF-M activity present in metaphase-arrested
and in interphase egg extracts (Fig. 2). Chromatin was li-
censed with serial dilutions of extract and transferred to
6-DMAP–treated extract, and the total DNA synthesized
over a 90-min incubation was measured (Fig. 2, filled cir-
cles). Consistent with the time courses shown in Fig. 1 b,
interphase extract efficiently licensed DNA synthesis after
dilution as low as 1/4–1/8 (Fig. 2 b). In contrast, no RLF
activity was provided by the metaphase-arrested extract
(Fig. 2 a).
The titrations of RLF activity in metaphase and inter-
phase extracts were repeated in the presence of exogenous
RLF-B (Fig. 2, open circles) or RLF-M (Fig. 2, open squares)
to respectively determine the RLF-M and RLF-B activity
of the samples. Titrations of activity in interphase extract
under these conditions remained virtually unchanged (Fig.
2  b), suggesting that these extracts had approximately
equal activities of RLF-M and RLF-B. At high concentra-
tions of metaphase extract, addition of exogenous RLF-B
or RLF-M induced no RLF activity (Fig. 2 a). However,
when metaphase extracts were diluted down to 1/8–1/16,
significant RLF-M activity could be detected. No RLF-B
activity was observed at any dilution of metaphase extract.
The appearance of RLF-M activity after dilution of meta-
phase extract was unexpected and suggested the presence
of an RLF inhibitor in these extracts that was being di-
luted away until it no longer inhibited the reaction. The
presence of an RLF inhibitor was demonstrated by mixing
serial dilutions of metaphase extract with a constant amount
of active RLF (RLF-B plus RLF-M; Fig. 2 a, triangles).
The licensing activity of exogenous RLF was inhibited by
high concentrations of metaphase extract. When meta-
phase extracts were diluted further, the inhibitory activity
was titrated away, allowing exogenous RLF to license chro-
matin. The disappearance of the inhibitory activity upon
dilution corresponded to concentrations where RLF-M ac-
tivity became assayable. In contrast, no RLF inhibitor was
observed in interphase extracts (Fig. 2 b, triangles). The
simplest explanation for the ability to assay RLF-M activ-
ity after dilution of metaphase extract is that the RLF in-
hibitor affects only RLF-B activity. Consistent with this in-
terpretation, we could find no evidence for the inhibition
of RLF-M activity in metaphase (see below).
To quantify cell cycle variations of RLF activity, extract
was incubated for various times, and then diluted to 1/8,
where RLF activity should be in the linear range for the
assay (Fig. 3). In these extracts, chromatin decondensation
and nuclear assembly are complete by z30–40 min after
CaCl2 addition, while S phase occurs at 40–90 min (Blow,
1993). RLF levels in metaphase were low, but, within 15
min after release from the metaphase arrest by CaCl2 ad-
dition, maximum levels of total RLF activity were ob-
served (Fig. 3 a, filled circles). Total RLF activity decayed
Figure 1. Effect of serial dilution on XMcm3 assembled onto
chromatin and rate of replication. Interphase Xenopus extract
was subjected to serial dilution, and 30-ml aliquots (or 60-ml for a,
lanes  3 and 10) were incubated with equal quantities (360 ng
DNA) of unlicensed chromatin (a, lanes 3–9; b) or sperm nuclei
(a, lanes 10–16) for 15 min at 238C. (a) Equal quantities of chro-
matin (z300 ng DNA) were isolated by centrifugation through
sucrose, run on a 7.5% polyacrylamide gel, and immunoblotted
with an anti-XMcm3 antibody. Dilutions were: (lanes 3 and 10)
undiluted (60 ml); (lanes 4 and 11) undiluted (30 ml); (lanes 5 and
12) 1/2; (lanes 6 and 13) 1/4; (lanes 7 and 14) 1/8; (lanes 8 and 15)
1/16; (lanes 9 and 16) 1/32. Samples of recombinant GST-tagged
XMcm3 (lane 1, 40 ng; lane 2, 20 ng) and interphase Xenopus egg
extract (lane 17, 0.125 ml; lane 18, 0.25 ml; lane 19, 0.5 ml) were
blotted in parallel. (b) Samples were transferred to 6-DMAP–
treated extract containing [a32P]dATP. The total DNA synthe-
sized at different times during an incubation at 238C was mea-
sured. Samples corresponding to the blots in a are indicated with
identical symbols.
Figure 2. RLF activity in serial dilutions of metaphase and inter-
phase extract. Metaphase arrested (a) or interphase (b) Xenopus
extracts were subjected to serial dilution, and then mixed with an
equal volume of either buffer ( ), crude RLF-B ( ), crude
RLF-M ( ), or a mixture of crude RLF-B and crude RLF-M
( ). B, buffer in place of diluted extract. Chromatin was incu-
bated in the mixture (12 ng DNA/ml) for 15 min at 238C to allow
licensing, and then was transferred to 2.5 vol 6-DMAP–treated
extract containing [a32P]dATP. The total DNA synthesized after
further incubation for 90 min at 238C was measured.Mahbubani et al. Regulation of the Replication Licensing System 129
over 1–2 h (Fig. 3 b, filled circles), although the kinetics of
the decay varied from extract to extract. This decay of to-
tal RLF activity was almost entirely due to decay of RLF-B
activity (Fig. 3 b, open squares), while RLF-M activity re-
mained fairly constant throughout the cell cycle (open cir-
cles).
Cdk Dependence of the RLF Inhibitor
The above results suggest the presence of an RLF inhibi-
tor in metaphase extracts. Interphase Xenopus extracts
can be induced to enter metaphase by addition of MPF, a
Cdk activity that can be provided by either Cdc2/cyclin B
(Labbé et al., 1989a; Gautier et al., 1990) or Cdc2/cyclin A
(Luca et al., 1991; Roy et al., 1991). We have previously
shown that the addition of high levels of cyclin A to inter-
phase Xenopus extracts inactivates RLF (Blow, 1993) and
blocks DNA replication (Strausfeld et al., 1996). We
therefore examined whether the RLF inhibitor present in
metaphase extracts was dependent on Cdk activity. Cy-
clin-dependent kinases can be affinity depleted from Xe-
nopus extracts using p13suc1 coupled to Sepharose beads
(Dunphy et al., 1988). When p13suc1 depletion is per-
formed on metaphase-arrested Xenopus extracts, subse-
quent DNA synthesis is blocked (Blow and Nurse, 1990).
Fig. 4 a (filled circles) shows that p13suc1 depleted meta-
phase extracts lack RLF activity. However, unlike the un-
depleted extracts (Fig. 2 a), RLF-M activity could be de-
tected at the highest extract concentrations (Fig. 4 a, open
circles). Thus, no RLF inhibitor could be detected in these
extracts (Fig. 4 a, triangles), and the lack of RLF activity
was apparently due only to a lack of RLF-B activity (Fig. 4 a,
squares).
The Xenopus early embryo has at least three distinct cy-
clin-dependent kinases: Cdc2/cyclin A, Cdc2/cyclin B, and
Cdk2/cyclin E. Similar to the effect of p13suc1 depletion,
immunoprecipitation of Cdc2 from metaphase extracts
blocked activation of RLF-B (data not shown) and pre-
vented subsequent DNA replication (Blow and Nurse,
1990). To demonstrate a direct role for Cdc2 in inhibiting
RLF, we prepared purified RLF-M (Chong et al., 1995)
and partially purified RLF-B (Rowles et al., 1996; Chong
et al., 1997). Incubation of recombinant Cdc2/cyclin B with
these purified fractions caused strong inhibition of licens-
ing (Fig. 4 b). This result strongly suggests that Cdc2/cyclin
B can directly inhibit the RLF system. Consistent with this
idea, we show below that stabilization of the RLF inhibitor
correlates well with stabilization of cyclin B.
We next performed a partial (z50-fold) purification
of RLF-M from metaphase and interphase extracts to
investigate whether active RLF-M can be found in a
metaphase-arrested extract (Fig. 5 a). RLF-M prepared
from metaphase extracts (RLF-Mmeta) showed virtually
identical activity to RLF-M prepared from interphase ex-
tracts (RLF-Minter). Mixing RLF-Mmeta and RLF-Minter to-
gether showed that the RLF-M had been purified away
from the metaphase-specific inhibitory activity. At this stage
we cannot be completely certain that RLF-M is fully active
in metaphase extracts, as it is possible that an inhibitory
modification (such as phosphorylation) might be reversed
during the purification protocol. In metaphase Xenopus
extracts, the XMcm4 protein, a component of RLF-M
(Chong et al., 1995; Thömmes, P., Y. Kubota, H. Tak-
isawa, and J.J. Blow, manuscript submitted for publica-
tion), is phosphorylated and migrates slower on SDS gels
(Fig. 5 b, lanes 1 and 3; Coué et al., 1996). This phosphory-
lation can be blocked with phosphatase inhibitor okadaic
acid (Fig. 5 b, lane 7; Coué et al., 1996), but is lost during
the purification of the RLF-Mmeta fraction (Fig. 5 b, lane 2).
However, the presence of the slow migrating form of
Figure 3. Time course of RLF activity during the in vitro cell cy-
cle. Interphase extract (b) or metaphase extract released into in-
terphase with CaCl2 (a) was incubated at 238C for various times.
Extract was then diluted eightfold and mixed with an equal vol-
ume of either buffer ( ), crude RLF-B ( ), or crude RLF-M
( ). Unlicensed chromatin was incubated in the mixture (12 ng
DNA/ml) for 15 min at 238C to allow licensing, and then was trans-
ferred to 2.5 vol 6-DMAP–treated extract containing [a32P]dATP.
The total DNA synthesized after further incubation for 90 min at
238C was measured. M, metaphase-arrested extract that was not
released with CaCl2.
Figure 4. Evidence for a Cdk-dependent RLF inhibitor.
(a) Metaphase-arrested extracts were depleted of Cdks with an
equal volume of p13suc1-coupled Sepharose. Depleted extract was
subjected to serial dilution, and then mixed with an equal volume
of either buffer ( ), crude RLF-B ( ), crude RLF-M ( ),
or a mixture of crude RLF-B and crude RLF-M ( ). B, buffer
in place of diluted extract. Unlicensed chromatin was incubated
in the mixture (12 ng DNA/ml) for 15 min at 238C to allow licens-
ing, and then was transferred to 2.5 vol 6-DMAP–treated extract
containing [a32P]dATP. The total DNA synthesized after further
incubation for 90 min at 238C was measured. (b) Preincubations
were performed for 15 min with different combinations of par-
tially purified RLF-B, purified RLF-M, and Cdc2/cyclin B (MPF).
Unlicensed chromatin was then added, and the incubation was
continued for an additional 15 min to allow licensing to occur.
Samples were then transferred to 6-DMAP–treated extract con-
taining [a32P]dATP, and the total DNA synthesized after further
incubation for 90 min at 238C was measured.The Journal of Cell Biology, Volume 136, 1997 130
XMcm4 does not correlate with the presence of the RLF
inhibitor, since XMcm4 is fast migrating in 6-DMAP–
treated extract (Fig. 5, lane 6) where the RLF inhibitor is
present (see below). Furthermore, XMcm4 is still slow mi-
grating in metaphase extracts diluted to 1/8 and incubated
with RLF-B (Fig. 5 b, lanes 8 and 9), under which condi-
tions the inhibitor has been titrated away (Fig. 2 a). Con-
versely, most of the XMcm4 is fast migrating in Suc1-
depleted extracts (Fig. 5 b, lane 5) where the inhibitor is
absent. Thus, we can find no evidence that mitotic phos-
phorylation of RLF-M inhibits its activity.
Since the RLF inhibitor present in metaphase extracts is
dependent on cyclin-dependent kinases, we next investi-
gated whether the decline in RLF activity during inter-
phase is also dependent on cyclin-dependent kinases. Both
cyclin A and cyclin B are abruptly degraded during late
mitosis, and must be resynthesized during the next cell cycle
before entry into mitosis. Therefore, treatment of Xeno-
pus egg extracts with protein synthesis inhibitors such as
cycloheximide blocks the reappearance of these two cy-
clins. However, consistent with our previous results (Blow,
1993), cycloheximide only slightly delayed the decay of
RLF that normally occurs during interphase (Fig. 6 a, half-
filled diamonds). In contrast to cyclins A and B, cyclin E
remains at approximately constant levels throughout the
early embryonic cell cycles (Rempel et al., 1995; Chevalier
et al., 1996). Treatment of Xenopus extracts with the Cdk2
inhibitor Cip1 inhibits the SPF activity of Cdk2/cyclin E
and thus blocks the initiation of DNA replication (Straus-
feld et al., 1994; Jackson et al., 1995). However, addition of
Cip1 to cycloheximide-treated extracts did not stabilize
RLF activity in the cell cycle (Fig. 6 a, filled diamonds).
Similarly, affinity depletion of Cdks from interphase ex-
tract using p13suc1-coupled Sepharose did not stabilize
RLF activity (data not shown). These results suggest that
the decay of RLF activity during interphase is indepen-
dent of Cdk activity.
Fig. 6 b shows the quantity of RLF-B and RLF-M activ-
ity in interphase extracts that had been incubated at 238C
for 2 h. Total RLF activity was reduced approximately
eightfold over extract that had recently been released
from metaphase (compare Figs. 2 b and 6 b, filled circles).
This was almost exclusively due to a loss of RLF-B activity
(open circles), while RLF-M activity remained high (squares).
Despite the decline in RLF-B activity, no RLF inhibitor
could be detected (Fig. 6 b, triangles). Thus, Xenopus ex-
tracts can be defective in RLF activity in at least two dis-
tinct ways. In metaphase, a potent inhibitor of RLF activ-
ity is present, and this inhibitor is directly dependent on
the presence of Cdk activity. If this inhibitor is diluted
away, RLF-M but not RLF-B activity can be detected. In
contrast, when RLF-B activity decays during late inter-
phase, this decay does not require Cdk activity and no
RLF inhibitor becomes activated.
Role of RLF in the Initiation of Replication
6-DMAP–treated extracts lack active RLF and therefore
cannot replicate double-stranded DNA (Blow, 1993). De-
spite this fact, they are still competent to support comple-
mentary strand synthesis on single-stranded DNA and to
elongate replication forks stalled with aphidicolin (Blow,
Figure 5. Features of RLF-M prepared from metaphase or inter-
phase extract. (a) Unlicensed chromatin was incubated for 15 min
at 238C with interphase extract, metaphase extract, or mixtures of
RLF-B and RLF-Mmeta (RLF-M prepared from metaphase extract)
and RLF-Minter (RLF-M prepared from interphase extract). Sam-
ples were then transferred to 6-DMAP–treated extract containing
[a32P]dATP. The total DNA synthesized after further incubation for
90 min at 238C was measured. (b) Protein samples electropho-
resed on a 7.5% polyacrylamide gel and immunoblotted with an
anti-XMcm4 antibody. Samples: 1, metaphase extract; 2, RLF-
Mmeta; 3, interphase extract; 4, RLF-Minter; 5, metaphase extract
depleted with p13suc1-Sepharose; 6, metaphase extract treated
with 3 mM 6-DMAP before CaCl2 release (6-DMAP–treated ex-
tract); 7, metaphase extract treated with 2 mM okadaic acid before
CaCl2 release; 8, metaphase extract diluted eightfold and incu-
bated for 15 min at 238C; 9, metaphase extract diluted eightfold,
mixed with crude RLF-B, and incubated for 15 min at 238C.
Figure 6. Effect of cycloheximide and Cip1 of RLF stability.
(a) Metaphase extract was released into interphase with CaCl2 ei-
ther untreated (control) or in the presence of 100 mg/ml cyclohex-
imide (1 CHX), or 100 mg/ml cycloheximide plus 150 nM p21Cip1
(1 CHX 1 Cip1). At the indicated times, samples were diluted
eightfold and incubated for 15 min with unlicensed chromatin.
Samples were then transferred to 6-DMAP–treated extract con-
taining [a32P]dATP. The total DNA synthesized after further in-
cubation for 90 min at 238C was measured. (b) Interphase extract
was incubated at 238C for 2 h to allow RLF activity to decay. The
extract was subjected to serial dilution, and then mixed with an
equal volume of either buffer ( ), crude RLF-B ( ), crude
RLF-M ( ), or a mixture of crude RLF-B and crude RLF-M
( ). B, buffer in place of diluted extract. Unlicensed chroma-
tin was incubated in the mixture (12 ng DNA/ml) for 15 min at
238C to allow licensing, and then was transferred to 2.5 vol
6-DMAP–treated extract containing [a32P]dATP. The total
DNA synthesized after further incubation for 90 min at 238C was
measured.
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1993). This suggests that RLF activity is required for the
initiation, but not the elongation, of replication forks. How-
ever, Yan and Newport (1995) have suggested on the basis
of immunofluorescence data that 6-DMAP–treated ex-
tracts are able to support the synthesis of DNA primers
at replication origins, but that these primers are not cor-
rectly processed into functional replication forks. We
therefore analyzed the residual DNA synthesis seen in
6-DMAP–treated extracts by alkaline gel electrophoresis
(Fig. 7 a) and BrdUTP density substitution (Fig. 7, b and
c). 6-DMAP treatment of the metaphase-arrested extract
inhibited subsequent DNA synthesis by 95%. However,
BrdU density substitution showed that all of the residual
DNA synthesized in the 6-DMAP–treated extract (Fig. 7 b)
was of the same density as DNA synthesized in untreated
extract (Fig. 7 c), as expected of fully replicated heavy/light
DNA produced by semiconservative replication. This sug-
gests that a small number of replicons escape the 6-DMAP
inhibition and produce relatively large tracts of fully repli-
cated DNA. This conclusion was confirmed by analyzing
nascent strand length by alkaline agarose gel electro-
phoresis (Fig. 7 a). In both 6-DMAP–treated (lane 1) and
untreated extract (lane 9), virtually all of the nascent DNA
was in the form of high molecular weight DNA (.23,000
nt in size). In contrast, when replication forks are stalled
close to the origin by treating extracts with aphidicolin,
most of the nascent DNA is observed in a broad smear of
between 100 and 300 nt in length (Fig. 7 a, lanes 5–8).
These results strongly suggest that 6-DMAP blocks the
initiation of DNA replication at a stage before significant
primer synthesis has occurred. The few replication forks
that do initiate in 6-DMAP–treated extracts then proceed
to synthesize extensive stretches of nascent DNA. No low
molecular weight products are observed when chromatin is
preincubated with RLF-B, RLF-M, or a mixture of both
before incubation in 6-DMAP–treated extract (Fig. 7 a, lanes
3–5), suggesting that both of these activities are required
for efficient initiation of DNA replication in 6-DMAP–
treated extracts.
Effect of 6-DMAP on the Licensing System
When 6-DMAP is added to metaphase-arrested Xenopus
extracts, MPF activity is inhibited, and the extracts sponta-
neously exit from metaphase into interphase without the
need for CaCl2 addition (Zhang and Masui, 1992; Blow,
1993). These 6-DMAP–treated extracts assemble DNA
into normal nuclei and, with the exception of RLF, contain
all the activities required for complete chromosome repli-
cation (Blow, 1993). Similar results have been reported for
two other kinase inhibitors: staurosporine (Blow, 1993;
Kubota and Takisawa, 1993) and olomoucine (Vesely et al.,
1994). For all these inhibitors, there is a good correlation
between the inhibition of MPF activity (as judged by spon-
taneous assembly of interphase nuclei) and the inhibition
of RLF activity. To cause inhibition of the licensing sys-
tem, the kinase inhibitors must be added to Xenopus ex-
tracts before exit from metaphase arrest (Blow, 1993; Ku-
bota and Takisawa, 1993). This suggests that the protein
kinase inhibitors block the RLF activation that normally
occurs upon exit from metaphase, rather than inhibiting
the action of active RLF. This conclusion is confirmed in
Fig. 8 a. Active RLF-M and RLF-B fractions prepared
from interphase Xenopus extract by differential PEG pre-
cipitation were resuspended in buffers plus or minus 3 mM
6-DMAP. This concentration of 6-DMAP is sufficient to
block RLF activation in metaphase extracts (Blow, 1993).
Efficient licensing of DNA replication required both RLF-
B and RLF-M, but it was not significantly affected by the
presence of 6-DMAP.
To measure RLF-B, RLF-M, and RLF inhibitor activity
when 6-DMAP is added to metaphase-arrested extracts, we
performed serial dilutions of 6-DMAP–treated metaphase
extract using buffer supplemented with an additional 3 mM
6-DMAP (Fig. 8 b). The results of the titration were strik-
ingly similar to those of untreated metaphase extracts
(compare Figs. 8 b and 2 a). RLF activity was not detected
at any dilution (Fig. 8 b, filled circles), but an RLF inhibi-
tor was detected at higher concentrations (triangles). Al-
though no RLF-B could be detected at any dilution
(squares), significant RLF-M activity could be detected
once the inhibitor had been diluted away (open circles). It
therefore appears that although the 6-DMAP–treated ex-
tracts have morphologically exited from metaphase into
interphase, they still contain the RLF inhibitor normally
present in metaphase extracts.
Figure 7. Analysis of the stage of replication blocked in 6-DMAP–
treated extracts. (a) Alkaline agarose gel of nascent DNA.
(Lanes  1–4) Chromatin was licensed for 15 min with either buffer
(lane 1), RLF-B (lane 2), RLF-M (lane 3), or RLF-B plus RLF-M
(lane  4), transferred to 6-DMAP–treated extract containing
[a32P]dATP, and incubated for 90 min. (Lanes 5–9) Sperm nuclei
was incubated for 90 min in interphase Xenopus extract contain-
ing [a32P]dATP and various concentrations of aphidicolin (lane 5,
30 mg/ml; lane 6, 20 mg/ml; lane 7, 10 mg/ml; lane 8, 5 mg/ml; lane 9,
no aphidicolin). To compensate for the much higher incorpora-
tion of 32P in the reactions, the total DNA loaded in lane 4 was re-
duced to 20%, and the total DNA in lane 9 was reduced to 10%.
(b and c) BrdUTP density substitution of nascent DNA synthe-
sized after incubation of sperm nuclei for 90 min in untreated (c)
or 6-DMAP–treated extract (b).The Journal of Cell Biology, Volume 136, 1997 132
Since the RLF inhibitor is dependent on the presence of
Cdk activity, we determined whether Cdc2/cyclin B is
present in 6-DMAP–treated extracts. Cyclins A and B are
normally degraded on exit from mitosis. Fig. 9 a shows an
autoradiograph of 35S-labeled cyclin B in extracts released
from metaphase by CaCl2 in the presence of different con-
centrations of 6-DMAP. Consistent with previous reports
(Felix et al., 1989; Luca and Ruderman, 1989), 6-DMAP at
concentrations of above 2 mM blocked cyclin B degrada-
tion that normally occurs after CaCl2 addition (Fig. 9 a,
lanes 5–8). However, these extracts all entered interphase
as judged by the assembly of DNA into interphase nuclei,
despite the stability of cyclin B at higher concentrations
(Fig. 9 b; 1CaCl2). Above 1 mM, 6-DMAP could inhibit
MPF and cause metaphase extract to spontaneously enter
interphase (as judged by the assembly of DNA into inter-
phase nuclei) in the absence of added CaCl2 (Fig. 9 b,
2CaCl2; Zhang and Masui, 1992). The concentrations of
6-DMAP just sufficient to block cyclin B degradation cor-
related well with concentrations at which RLF became sta-
bly inhibited (Fig. 9 c). It therefore seems most likely that
while high levels of Cdc2 kinase are required to trigger cy-
clin B degradation (Felix et al., 1989), lower levels of ki-
nase sufficient to inhibit RLF activity are still present in
extracts treated with 3 mM 6-DMAP.
Discussion
RLF is an essential initiation factor that ensures that chro-
mosomal DNA is not re-replicated in a single cell cycle. In
this paper we measure the RLF activity present in Xeno-
pus extracts and show that the ability of extracts to license
chromatin varies throughout the cell cycle. In metaphase
extract, RLF-M but not RLF-B activity can be assayed,
and, in addition, an RLF inhibitor is present. This RLF in-
hibitor is dependent on the presence of cyclin-dependent
kinases and is stabilized when cyclin B is stabilized by the
protein kinase inhibitor 6-DMAP. RLF activity is rapidly
activated upon exit from metaphase, and then decays dur-
ing late interphase. The decay of RLF activity in late inter-
phase is mainly due to decay of RLF-B activity and is not
associated with reactivation of the RLF inhibitor.
RLF Activity of Xenopus Egg Extracts
Interphase  Xenopus extract can license z100–200 ng
Figure 8. Effect of 6-DMAP on RLF activity. (a) Unlicensed
chromatin was incubated for 15 min plus or minus 3 mM 6-DMAP
with crude RLF-B, crude RLF-M, or a mixture of the two. Sam-
ples were then transferred to 6-DMAP–treated extract contain-
ing [a32P]dATP. The total DNA synthesized after further incuba-
tion for 90 min at 238C was measured. (b) Metaphase-arrested
Xenopus extract was treated with 3 mM 6-DMAP and 0.3 mM
CaCl2, followed by serial dilution in buffer containing 3 mM
6-DMAP. Samples were then mixed with equal volumes of either
buffer ( ), crude RLF-B ( ), crude RLF-M ( ), or a mix-
ture of crude RLF-B and crude RLF-M ( ). B, buffer in place of
diluted extract. Chromatin was incubated in the mixture (12 ng
DNA/ml) for 15 min at 238C to allow licensing, and then was trans-
ferred to 2.5 vol 6-DMAP–treated extract containing [a32P]dATP.
The total DNA synthesized after further incubation for 90 min at
238C was measured.
Figure 9. Titration of 6-DMAP into metaphase extract. (a) Meta-
phase extract was labeled for 20 min with [35S]methionine, and
then was supplemented with 100 mg/ml cycloheximide and the in-
dicated concentrations of 6-DMAP. Extract was then further sup-
plemented plus (lanes 2–8) or minus (lane 1) 0.3 mM CaCl2. Af-
ter incubation at 238C for 30 min, cyclin–Cdk complexes were
collected on p13suc1 beads, electrophoresed on polyacrylamide
gels, and autoradiographed. The migration of cyclin B is indi-
cated. (b) Metaphase extract was supplemented with sperm nu-
clei (3 ng DNA/ml) and various concentrations of 6-DMAP, plus
(lower panel) or minus (upper panel) 0.3 mM CaCl2. The mor-
phology of chromatin after 1.5 h at 238C was assessed by micros-
copy: (h), condensed chromosomes; (j), interphase nuclei; ( ),
partial nuclear assembly. (c) Metaphase extract was supple-
mented with sperm nuclei (3 ng DNA/ml), 0.3 mM CaCl2,
[a32P]dATP, and various concentrations of 6-DMAP. The total
DNA synthesized after 3 h at 238C was measured.Mahbubani et al. Regulation of the Replication Licensing System 133
DNA per ml extract for efficient replication. Titration of
RLF-M and RLF-B activity suggested that these two activ-
ities were present at approximately equal levels. Chroma-
tin licensed at 100 ng DNA per ml extract could replicate
at rates typical of Xenopus egg extracts. Western blotting
of XMcm3, a component of RLF-M (Chong et al., 1995),
suggests that, at 100 ng DNA per ml extract, one XMcm3
molecule is assembled on average onto every 5–10 kb
DNA. This represents on average one to three XMcm3
molecules per replicon. However, at lower concentrations
of DNA, more XMcm3 can be assembled onto chromatin
(up to one XMcm3 molecule per 1.5 kb, or 10 XMcm3
molecules per replicon) without significantly affecting the
overall replication rate. This higher density of XMcm3 is
more likely to reflect conditions in vivo, since up to the
midblastula transition (when zygotic transcription starts),
the concentration of chromosomal DNA is ,25 ng/ml. A
similar excess of Mcm3 over replication origins has been
reported in human cells (Burkhart et al., 1995) and bud-
ding yeast (Lei et al., 1996).
Cell Cycle Variation of RLF Activity
RLF activity varies throughout the in vitro cell cycle. In
metaphase, RLF is largely inactive but is rapidly activated
after the metaphase–anaphase transition; during inter-
phase, activity then gradually declines (Blow, 1993). We
have analyzed some of the basic causes of this variation. In
metaphase an RLF inhibitor was present that inhibited li-
censing by exogenous RLF. When this metaphase extract
was diluted so that the inhibitor no longer interfered with
the licensing assay, levels of RLF-M were detected compa-
rable with those seen in interphase extract. In contrast, no
RLF-B activity was detected. Partially purified RLF-M
prepared from metaphase extracts (RLF-Mmeta) was also
fully active. XMcm4, a component of RLF-M (Thömmes,
P., Y. Kubota, H. Takisawa, and J.J. Blow, manuscript
submitted for publication), was phosphorylated during
metaphase (Coué et al., 1996), but this phosphorylated
XMcm4 was still associated with active RLF-M. The sim-
plest explanation for these results is that the target of the
RLF inhibitor is RLF-B, not RLF-M, although we cannot
completely rule out an inhibitory modification to RLF-M
that we have been unable to stabilize.
The decline of RLF activity that occurs during inter-
phase causes a different defect than is seen in metaphase
extracts. RLF-M activity remains high, but RLF-B activity
declines. Unlike metaphase extracts, the loss of RLF-B ac-
tivity during interphase occurs without the appearance
of an RLF inhibitor. At present we cannot be certain
whether the decline of RLF-B activity during interphase is
of physiological relevance or whether it is an artifact of the
cell-free system. However, the decline of RLF-B activity is
fairly specific, since extracts retain RLF-M activity and re-
main competent to replicate previously licensed chromatin
(Blow, 1993).
Role of RLF in the Initiation of Replication
The initiation of chromosomal DNA replication is likely
to consist of several steps, including the unwinding of ori-
gin DNA, the synthesis of short DNA primers, and the es-
tablishment of a mature replication fork. On the basis of
immunofluorescence data showing that 6-DMAP–treated
extracts are able to support low levels of DNA synthesis, it
has been suggested that RLF is not required for the syn-
thesis of DNA primers at replication origins, but it is re-
quired for correct assembly of replication forks (Yan and
Newport, 1995). We have examined this point in detail to
determine whether RLF is required for the synthesis of
DNA primers early in initiation. Alkaline gel electro-
phoresis of nascent strands showed that in 6-DMAP–
treated extracts lacking RLF, no short DNA primers could
be observed. In contrast, short nascent strands could be
readily detected when replication forks were blocked by
the polymerase inhibitor aphidicolin. Both RLF-B and
RLF-M were required for efficient DNA replication, but
in the presence of both these activities, nascent strands
were rapidly extended into high molecular weight DNA.
We therefore conclude that RLF is required for the initia-
tion of DNA replication before the synthesis of DNA
primers.
The RLF Inhibitor Depends on Cdk Activity
Cdks are key regulators of cell cycle progression (for re-
view see Nigg, 1995). MPF is an activity present in meta-
phase cells capable of inducing entry into mitosis. It con-
sists of a Cdc2/cyclin B heterodimer (Dunphy et al., 1988;
Gautier et al., 1988, 1990; Labbé et al., 1989a,b). Cdc2/cy-
clin A, which is also active at this stage of the cell cycle,
can also generate MPF activity (Luca et al., 1991; Roy et al.,
1991; Strausfeld et al., 1996). The RLF inhibitor present in
metaphase extracts appears to be directly dependent on
Cdks active at this time. When Cdks were affinity depleted
from metaphase extracts using p13suc1, the RLF inhibitor
was removed. Inhibition of RLF function by kinase inhibi-
tors such as 6-DMAP caused persistence into interphase
state of the RLF inhibitor normally only present during
metaphase. This also correlated with inhibition of MPF ac-
tivity (Blow, 1993; Kubota and Takisawa, 1993; Vesely et al.,
1994) and stabilization of cyclin B. Active RLF was also
inhibited by the activation of Cdks. When recombinant
cyclin A was added to interphase extract, RLF activity
abruptly decayed (Blow, 1993). Furthermore, purified
Cdc2/cyclin B directly inhibited licensing activity provided
by purified RLF-M and partially purified RLF-B. These
results strongly suggest a direct inhibition of the licensing
system by Cdc2 kinase. Although MCM/P1 polypeptides
are expected to be good substrates for this kinase (Coué
et al., 1996), the results discussed above suggest that inhi-
bition of licensing is unlikely to be mediated by inhibition
of RLF-M function. Instead, RLF-B appears to be a more
likely target of Cdk inhibition.
Inhibition of RLF function by Cdks is consistent with
experiments in other organisms that show, when Cdk ac-
tivity is inhibited in G2 cells, re-replication of chromo-
somal DNA can occur without cells passing into mitosis.
This effect is plausibly caused by reactivation of RLF and
relicensing of replicated DNA. Re-replication of chromo-
somal DNA is seen in Saccharomyces pombe cells contain-
ing a temperature-sensitive cdc2 gene when they are
shifted to the nonpermissive temperature during G2 (Broek
et al., 1991). Repeated rounds of DNA synthesis are seen
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et al., 1994) or cells that overexpress the Cdc2 inhibitor
Rum1 (Moreno and Nurse, 1994). In S. cerevisiae, the es-
tablishment of a pre-replicative footprint over origins of
replication that probably corresponds to the licensed state
can only occur in late mitosis and G1 when Cdk levels are
low (Diffley et al., 1994; Piatti et al., 1996). Furthermore,
inhibition of Cdks in G2/M-phase S. cerevisiae cells is suffi-
cient to induce a pre-replicative footprint over origins of
replication (Dahmann et al., 1995). Treatment of mamma-
lian cells with certain protein kinases that inhibit Cdks was
sufficient to allow re-replication of DNA in the absence of
mitosis (Usui et al., 1991). Similar treatments allow mam-
malian G2 nuclei to become relicensed for replication in
Xenopus egg extracts (Coverley et al., 1996). A require-
ment for Cdks to prevent re-replication of DNA late in the
cell cycle therefore appears widespread throughout the
eukaryotic kingdom and is plausibly mediated by an RLF
inhibitor that prevents relicensing of replicated DNA. This
is consistent with the results presented here demonstrating
a Cdk-dependent RLF inhibitor present in metaphase ex-
tract.
However, RLF regulation in the Xenopus system ap-
pears somewhat different from that in the other cell types.
First, loss of cytoplasmic RLF during interphase in Xeno-
pus is not dependent on Cdk activity and is not associated
with an RLF inhibitor. Secondly, although relicensing of
DNA is dependent on nuclear envelope permeabilization
in both Xenopus and Drosophila cell-free systems (Blow
and Laskey, 1988; Crevel and Cotterill, 1991), this does
not seem necessary in other cell types. One attractive ex-
planation for these apparent differences is that in Xeno-
pus, relicensing of DNA in replicated nuclei is prevented
by a Cdk-dependent inhibitor that is active only within the
nucleus. Permeabilization of the nuclear envelope would
then release the inhibitor and permit relicensing of the
DNA by RLF-B and RLF-M.
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